CAPRICOR THERAPEUTICS INC's ticker is CAPR and the CUSIP is 14070B101. A total of 18 filers reported holding CAPRICOR THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $55,000 | -42.7% | 118,686 | -50.0% | 0.00% | – |
| Q4 2018 | $96,000 | -22.6% | 237,372 | +100.0% | 0.00% | – |
| Q3 2018 | $124,000 | -22.0% | 118,686 | 0.0% | 0.00% | – |
| Q2 2018 | $159,000 | +52.9% | 118,686 | +54.1% | 0.00% | – |
| Q1 2018 | $104,000 | -14.0% | 76,996 | 0.0% | 0.00% | – |
| Q4 2017 | $121,000 | -24.4% | 76,996 | +44.9% | 0.00% | – |
| Q3 2017 | $160,000 | +263.6% | 53,121 | 0.0% | 0.00% | – |
| Q2 2017 | $44,000 | -71.4% | 53,121 | +14.5% | 0.00% | – |
| Q1 2017 | $154,000 | +32.8% | 46,387 | +5.6% | 0.00% | – |
| Q4 2016 | $116,000 | -20.0% | 43,929 | 0.0% | 0.00% | – |
| Q3 2016 | $145,000 | -16.2% | 43,929 | 0.0% | 0.00% | – |
| Q2 2016 | $173,000 | +55.9% | 43,929 | 0.0% | 0.00% | – |
| Q1 2016 | $111,000 | -17.2% | 43,929 | 0.0% | 0.00% | – |
| Q4 2015 | $134,000 | -24.3% | 43,929 | 0.0% | 0.00% | – |
| Q3 2015 | $177,000 | -19.9% | 43,929 | 0.0% | 0.00% | – |
| Q2 2015 | $221,000 | – | 43,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coastal Bridge Advisors, LLC | 118,941 | $49,000 | 0.02% |
| Apriem Advisors | 50,000 | $21,000 | 0.01% |
| Cordasco Financial Network | 3,100 | $1,000 | 0.00% |
| BROWN ADVISORY INC | 852,566 | $350,000 | 0.00% |
| UBS Group AG | 13,935 | $6,000 | 0.00% |
| ROYAL BANK OF CANADA | 34 | $0 | 0.00% |
| Advisor Group, Inc. | 3,000 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 237,372 | $96,000 | 0.00% |
| BlackRock Inc. | 45,145 | $18,000 | 0.00% |
| Bank of New York Mellon Corp | 25,097 | $10,000 | 0.00% |